Streetbeat News

Regulatory

ABT

EBS

MRNA

SIGA

The World Health Organization (WHO) announced that an expert committee will propose the adoption of Mpox vaccines under Emergency Use Listing around mid-September.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:55 pm

SPY

THD

The U.S. State Department has acknowledged the ruling by the Thai Constitutional Court to dismiss the Prime Minister of Thailand.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:52 pm

ARWR

Arrowhead Pharmaceuticals (NASDAQ: ARWR) announced plans to advance two new RNAi-based obesity candidates, ARO-INHBE and ARO-ALK7, into clinical studies. These candidates have shown potential in preclinical studies to reduce body weight and fat mass while preserving lean muscle mass. Arrowhead will submit clinical trial applications by the end of 2024 and aims to start clinical studies in early 2025.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:31 pm

GOVX

GeoVax Labs shares are trading higher following the WHO Director General's declaration that Mpox is a public health emergency of international concern.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:30 pm

SIGA

SIGA Technologies shares are trading higher following a report suggesting the WHO Director General said Mpox is a public health emergency of international concern.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:29 pm

AEMD

CMRX

GOVX

INO

MRNA

SIGA

TNXP

WHO Director-General Tedros Adhanom Ghebreyesus has declared Mpox a Public Health Emergency of International Concern. This announcement could impact companies involved in vaccine and treatment development for Mpox.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:27 pm

SPY

VGK

The U.S. State Department is aware of reports regarding the detention of another American citizen in Russia and is working to gather more information.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:25 pm

AEMD

CMRX

GOVX

INO

MRNA

SIGA

TNXP

The World Health Organization (WHO) has begun a press conference to discuss the potential declaration of an emergency regarding the Mpox virus. This could have significant implications for companies involved in the development of vaccines and treatments for the virus.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:25 pm

XXII

22nd Century Group has received a Notice of Allowance for its U.S. Patent Application 17/785,153 titled 'GENETIC APPROACH FOR ACHIEVING ULTRA LOW NICOTINE CONTENT IN TOBACCO'.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:07 pm

GILD

The FDA has approved Gilead Sciences' new drug, Livdelzi, for the treatment of Primary Biliary Cholangitis, according to Reuters citing the company's website.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:03 pm